Podcast

Philip O. Anderson, PharmD, on Safe Medication Use for IBS During Breastfeeding

10/01/2019

 

Philip O. Anderson, PharmD, from the University of California, San Diego, discusses medication use during breastfeeding among women with irritable bowel syndrome (IBS), which medications are safe for use, the importance of encouraging patients with IBS to continue breastfeeding, and more.

Philip O. Anderson, PharmD, is Health Sciences Clinical Professor of Pharmacy at the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California, San Diego.

 

 

Related Content

Critical Care
Critical Care
The Evolving Critical Care Workforce Crisis: Women Leaders in Critical Care, Ep. 2
12/24/2020
Moderator Jaspal Singh, MD, MHA, MHS, interviews Meeta Kerlin, MD, MSCE, and Sue Stempek, PA-C, about the critical care workforce crisis, how the COVID-19 pandemic affected this crisis, and how being a...
12/24/2020
Infectious Diseases
Infectious Diseases
Michael Reid, MD, on Updates on Diagnostics and Treatment for HIV-TB Coinfection
03/25/2019
In this podcast, Michael Reid, MD, from University of California, San Francisco, discusses how the landscape of diagnosing and treating HIV-TB coinfection has changed over the years and what it has evolved...
03/25/2019
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Jean-Frederic Colombel, MD, on Multidisciplinary Approach Is Needed to Manage Challenges in IBD
12/10/2018
Dr Jean-Frederic Colombel from Mount Sinai Medical Center discusses clinical challenges in inflammatory bowel disease for 2019, the need for a multidisciplinary approach, and more.
12/10/2018
Cardiometabolic Risk
Cardiometabolic Risk
Daniel Einhorn, MD, on Treating CVD in Diabetes
02/06/2019
Dr Daniel Einhorn from the Scripps Whittier Diabetes Institute talks about how the latest diabetes guidelines impacts treatment for patients with comorbid cardiovascular disease.
02/06/2019
HIV Prevention
HIV Prevention
Daniel R. Kuritzkes, MD, on HIV Resistance After PrEP
10/14/2021
He talks about HIV resistance in the context of pre-exposure prophylaxis use, how common it is, and how PrEP might influence subsequent therapies.
10/14/2021